This announcement is a separate document:
东兴证券股份有限公司关于中源协和细胞基因工程股份有限公司2023年度募集资金存放与使用情况的专项核查意见
Dongxing Securities Co., Ltd.'s special inspection opinion on the storage and use of funds raised by Zhongyuan Xiehe Cytogenetic Engineering Co., Ltd. in 2023
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.